KETOSTERIL (ketoanalogues), combination of amino acids
NEPHROLOGY - New medicinal product
Opinions on drugs -
Posted on
Jul 10 2015
Reason for request
Inclusion
No clinical benefit demonstrated in combination with a very low protein diet in chronic renal failure
KETOSTERIL has Marketing Authorisation, in combination with a very low protein diet (0.4 g/kg/day) in chronic renal failure, to reduce the uraemic syndrome and better control the phosphorous-calcium metabolism.
The data from clinical studies having evaluated its efficacy and safety are fragmentary.
Its actual benefit is low and does not provide any improvement in the management of patients with chronic renal failure in combination with a very low protein diet.
Clinical Benefit
Low |
- |
Clinical Added Value
no clinical added value |
- |
Therapeutic use
- |
English version
Contact Us
Évaluation des médicaments